AUTHOR=Roth Claude , Cantaert Tineke , Colas Chloé , Prot Matthieu , Casadémont Isabelle , Levillayer Laurine , Thalmensi Jessie , Langlade-Demoyen Pierre , Gerke Christiane , Bahl Kapil , Ciaramella Giuseppe , Simon-Loriere Etienne , Sakuntabhai Anavaj TITLE=A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice JOURNAL=Frontiers in Immunology VOLUME=10 YEAR=2019 URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.01424 DOI=10.3389/fimmu.2019.01424 ISSN=1664-3224 ABSTRACT=
Dengue virus (DENV) induces strong T and B cell responses upon infection. Hence, it is difficult to determine the contribution of cell-mediated immunity alone in the long lasting protection against DENV infection and disease. Numerous CD4+ and CD8+ T cell epitopes have been identified, mainly in the non-structural proteins of DENV. Taking into account the immunogenicity and peptide sequence conservation among the different DENV serotypes, a minimal DENV antigen, called DENV1-NS, has been designed. This antigen is enriched in conserved and highly antigenic epitopes located in the NS3, NS4B, and NS5 regions of DENV1. To evaluate the ability of the DENV1-NS poly-epitope to express the antigenic peptides in the context of different HLA class I molecules, we established its